Company Filing History:
Years Active: 2007-2010
Title: Tom Grunberger: Innovator in Cell Proliferation Modulation
Introduction
Tom Grunberger is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of therapeutic methods and compositions, particularly in the modulation of abnormal cell proliferation. With a total of 3 patents, his work has implications for both research and clinical applications.
Latest Patents
Grunberger's latest patents focus on compounds that are useful for modulating abnormal cell proliferation. These compounds, described in various formulae, are intended for use in therapeutic methods, diagnostic assays, and as research tools. The compounds include a range of functional groups and are designed to interact with various biological pathways, showcasing their potential in medical applications.
Career Highlights
Throughout his career, Tom Grunberger has worked with prestigious institutions, including The Hospital for Sick Children. His innovative research has contributed to advancements in understanding and treating conditions related to cell proliferation.
Collaborations
Grunberger has collaborated with esteemed colleagues such as Chaim M. Roifman and Peter M. Demin. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Tom Grunberger's work in the field of cell proliferation modulation exemplifies the importance of innovation in medical research. His patents and collaborations highlight his commitment to advancing therapeutic methods and improving health outcomes.